Anthony V. D’Amico

15.5k total citations · 5 hit papers
141 papers, 9.4k citations indexed

About

Anthony V. D’Amico is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Statistics and Probability. According to data from OpenAlex, Anthony V. D’Amico has authored 141 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Pulmonary and Respiratory Medicine, 23 papers in Surgery and 23 papers in Statistics and Probability. Recurrent topics in Anthony V. D’Amico's work include Prostate Cancer Treatment and Research (118 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Statistical Methods in Clinical Trials (23 papers). Anthony V. D’Amico is often cited by papers focused on Prostate Cancer Treatment and Research (118 papers), Prostate Cancer Diagnosis and Treatment (116 papers) and Statistical Methods in Clinical Trials (23 papers). Anthony V. D’Amico collaborates with scholars based in United States, Germany and Canada. Anthony V. D’Amico's co-authors include Andrew A. Renshaw, Philip W. Kantoff, Ming‐Hui Chen, Marian Loffredo, Jerome P. Richie, Judith Manola, Judd W. Moul, Peter R. Carroll, Massimo Loda and Christine Ladd and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Anthony V. D’Amico

135 papers receiving 9.1k citations

Hit Papers

Gene expression correlate... 2002 2026 2010 2018 2002 2010 2007 2004 2008 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anthony V. D’Amico 6.5k 2.1k 1.4k 1.1k 951 141 9.4k
S. Larry Goldenberg 6.0k 0.9× 929 0.4× 1.3k 1.0× 964 0.8× 1.1k 1.1× 190 8.8k
Misop Han 9.9k 1.5× 1.7k 0.8× 1.7k 1.3× 1.7k 1.5× 2.2k 2.3× 225 12.1k
Chris Parker 8.5k 1.3× 1.6k 0.8× 2.5k 1.8× 1.7k 1.5× 1.4k 1.5× 245 11.2k
David G. McLeod 9.7k 1.5× 3.0k 1.4× 2.5k 1.8× 2.4k 2.1× 1.9k 2.0× 271 13.3k
R. Jeffrey Karnes 8.5k 1.3× 2.3k 1.1× 2.0k 1.4× 2.4k 2.1× 2.8k 3.0× 428 12.4k
Charles R. Pound 5.1k 0.8× 886 0.4× 644 0.5× 837 0.7× 945 1.0× 42 6.0k
Leslie A. Mangold 4.5k 0.7× 1.2k 0.6× 811 0.6× 934 0.8× 885 0.9× 91 5.8k
Judith Manola 6.5k 1.0× 4.9k 2.3× 4.8k 3.5× 2.4k 2.1× 1.9k 2.0× 189 14.2k
E. David Crawford 4.9k 0.7× 1.2k 0.6× 1.3k 0.9× 956 0.8× 1.0k 1.1× 161 6.8k
Leonard S. Marks 7.3k 1.1× 1.3k 0.6× 482 0.4× 913 0.8× 1.0k 1.1× 205 9.6k

Countries citing papers authored by Anthony V. D’Amico

Since Specialization
Citations

This map shows the geographic impact of Anthony V. D’Amico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony V. D’Amico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony V. D’Amico more than expected).

Fields of papers citing papers by Anthony V. D’Amico

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony V. D’Amico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony V. D’Amico. The network helps show where Anthony V. D’Amico may publish in the future.

Co-authorship network of co-authors of Anthony V. D’Amico

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony V. D’Amico. A scholar is included among the top collaborators of Anthony V. D’Amico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony V. D’Amico. Anthony V. D’Amico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Ming‐Hui, Marian Loffredo, Elizabeth McMahon, et al.. (2024). Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial. Cancer. 130(13). 2287–2293. 1 indexed citations
3.
King, Martin T., Ming‐Hui Chen, Laurence Collette, et al.. (2021). Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer. JAMA Network Open. 4(5). e2111092–e2111092. 5 indexed citations
4.
Preißer, Felix, Matthew R. Cooperberg, Juanita Crook, et al.. (2020). Intermediate-risk Prostate Cancer: Stratification and Management. European Urology Oncology. 3(3). 270–280. 59 indexed citations
5.
Tan, Xiang‐Lin, E Jian‐Yu, Yong Lin, et al.. (2020). Individual and joint effects of metformin and statins on mortality among patients with high‐risk prostate cancer. Cancer Medicine. 9(7). 2379–2389. 23 indexed citations
6.
Dee, Edward Christopher, Brandon A. Mahal, Anthony V. D’Amico, et al.. (2020). Relative Timing of Radiotherapy and Androgen Deprivation for Prostate Cancer and Implications for Treatment During the COVID-19 Pandemic. JAMA Oncology. 6(10). 1630–1630. 18 indexed citations
7.
Mahal, Brandon A., David R. Ziehr, Ayal A. Aizer, et al.. (2014). Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer. Urologic Oncology Seminars and Original Investigations. 32(8). 1285–1291. 71 indexed citations
8.
Lester-Coll, N.H., Samuel Z. Goldhaber, David J. Sher, & Anthony V. D’Amico. (2013). Death from high‐risk prostate cancer versus cardiovascular mortality with hormonal therapy. Cancer. 119(10). 1808–1815. 24 indexed citations
9.
Nanda, Akash, Ming‐Hui Chen, Brian J. Moran, et al.. (2009). Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1439–1444. 9 indexed citations
10.
Nguyen, Paul L., Ming‐Hui Chen, Clair J. Beard, et al.. (2009). Radiation With or Without 6 Months of Androgen Suppression Therapy in Intermediate- and High-Risk Clinically Localized Prostate Cancer: A Postrandomization Analysis by Risk Group. International Journal of Radiation Oncology*Biology*Physics. 77(4). 1046–1052. 30 indexed citations
11.
D’Amico, Anthony V., Ming‐Hui Chen, Andrew A. Renshaw, Marian Loffredo, & Philip W. Kantoff. (2008). Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer. JAMA. 299(3). 289–95. 491 indexed citations breakdown →
12.
Nguyen, Paul L., Ming‐Hui Chen, William J. Catàlona, et al.. (2008). Predicting Prostate Cancer Mortality Among Men With Intermediate to High-Risk Disease and Multiple Unfavorable Risk Factors. International Journal of Radiation Oncology*Biology*Physics. 73(3). 659–664. 52 indexed citations
13.
D’Amico, Anthony V., Ming‐Hui Chen, Andrew A. Renshaw, Marian Loffredo, & Philip W. Kantoff. (2008). Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer. Cancer. 113(12). 3290–3297. 29 indexed citations
14.
D’Amico, Anthony V., James W. Denham, Juanita Crook, et al.. (2007). Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions. Journal of Clinical Oncology. 25(17). 2420–2425. 371 indexed citations
15.
D’Amico, Anthony V., Andrew A. Renshaw, Brenda Sussman, & Ming‐Hui Chen. (2005). Pretreatment PSA Velocity and Risk of Death From Prostate Cancer Following External Beam Radiation Therapy. JAMA. 294(4). 440–440. 225 indexed citations
16.
D’Amico, Anthony V., et al.. (2004). 6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer. JAMA. 292(7). 821–821. 599 indexed citations breakdown →
17.
D’Amico, Anthony V., Judd W. Moul, Peter R. Carroll, et al.. (2004). Intermediate End Point for Prostate Cancer-Specific Mortality Following Salvage Hormonal Therapy for Prostate-Specific Antigen Failure. JNCI Journal of the National Cancer Institute. 96(7). 509–515. 28 indexed citations
18.
Kantoff, Philip W., Peter R. Carroll, Anthony V. D’Amico, et al.. (2002). Prostate cancer : principles and practice. Lippincott Williams & Wilkins eBooks. 52 indexed citations
19.
Singh, Dinesh, Phillip G. Febbo, Kenneth N. Ross, et al.. (2002). Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 1(2). 203–209. 1823 indexed citations breakdown →
20.
Wicks, Ian P., et al.. (1997). Use of monoclonal antibodies to detect disease associated HLA-DRB1 alleles and the shared epitope in rheumatoid arthritis. Annals of the Rheumatic Diseases. 56(2). 135–139. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026